Pharma Pulse: ACA Subsidy Gridlock Spurs Cost Crisis, as Lilly’s Retatrutide Delivers Positive Results in Phase III Trial

Dec 12, 10:30 AM

Headliner
Share
Subscribe
In today’s Pharma Pulse, the Senate fails to advance bills extending enhanced ACA subsidies, leaving 22 million enrollees facing sharp premium increases, and much more.
Share
Subscribe
Next
Pharma Pulse: Amgen's Uplizna Secures CD19 Approval for Myasthenia Gravis, as Asthma Biologic Switches Highlight Efficacy Expectations Gap
Top episodes
Incorporating AI into Commercialization Plans
by Pharmaceutical Commerce
Overcoming Supply Chain Challenges
by Pharmaceutical Commerce
The Capabilities of a 3PL Provider
by Pharmaceutical Commerce